Choriocapillaris Integrity in Relapsed Central Serous Chorioretinopathy in a Patient Treated With Fingolimod for Multiple Sclerosis: New Insights From Optical Coherence Tomography Angiography

J Neuroophthalmol. 2021 Mar 1;41(1):e51-e53. doi: 10.1097/WNO.0000000000000937.

Authors

Lucia Ziccardi¹, Doriana Landi, Daniele De Geronimo, Lucilla Barbano, Paola Giorno, Girolama Alessandra Marfia, Maria Albanese, Vincenzo Parisi, Mariacristina Parravano

Affiliation

¹ Neurophysiology of Vision and Neuroophthalmology Unit (LZ, LB, VP), IRCCS-Fondazione Bietti, Rome, Italy; Medical Retina Unit (DDG, PG, MP), IRCCS-Fondazione Bietti, Rome, Italy; and Multiple Sclerosis Clinical and Research Unit (DL, GAM, MA), Department of Systems Medicine, Tor Vergata University, Rome, Italy .

PMID: 32235227
DOI: 10.1097/WNO.0000000000000937

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Central Serous Chorioretinopathy / diagnostic imaging
Central Serous Chorioretinopathy / physiopathology*
Choroid / blood supply*
Choroid / diagnostic imaging
Coloring Agents / administration & dosage
Fingolimod Hydrochloride / therapeutic use*
Fluorescein Angiography
Humans
Immunosuppressive Agents / therapeutic use*
Indocyanine Green / administration & dosage
Male
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Recurrence
Tomography, Optical Coherence
Visual Acuity / physiology

Substances

Coloring Agents
Immunosuppressive Agents
Fingolimod Hydrochloride
Indocyanine Green